ticlopidine has been researched along with Systemic Inflammatory Response Syndrome in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolf, I | 1 |
| Mouallem, M | 1 |
| Rath, S | 1 |
| Farfel, Z | 1 |
| López-Vicente, J | 1 |
| Garfia, C | 1 |
| López-Medrano, F | 1 |
| Yela, C | 1 |
2 other studies available for ticlopidine and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
Clopidogrel-induced systemic inflammatory response syndrome.
Topics: Clopidogrel; Coronary Angiography; Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Ste | 2003 |
[Hepatic toxicity and clopidogrel-induced systemic inflammatory response syndrome].
Topics: Chemical and Drug Induced Liver Injury; Clopidogrel; Humans; Male; Middle Aged; Platelet Aggregation | 2007 |